StockDriftsStockDriftsTop 50 Perceptive Advisors LLC Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| PRAX | PRAXIS PRECISION MEDICINES I | 12.97% | 2.04M | $656.0M | +2.00%(+40.00K) | $79.33(+301.52%) | 2026-03-31 | |
| CELC | CELCUITY INC | 7.06% | 3.13M | $356.9M | -1.04%(-33.00K) | $29.38(+267.44%) | 2026-03-31 | |
| ASND | ASCENDIS PHARMA A/S | 6.93% | 1.53M | $350.3M | +41.61%(+450.00K) | $177.66(+54.51%) | 2026-03-31 | |
| ROIV | ROIVANT SCIENCES LTD | 4.54% | 8.29M | $229.5M | +3.76%(+300.00K) | $12.69(+176.86%) | 2026-03-31 | |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 4.13% | 5.26M | $208.9M | +80.25%(+2.34M) | $23.17(+74.81%) | 2026-03-31 | |
| RYTM | RHYTHM PHARMACEUTICALS INC | 4.08% | 2.37M | $206.4M | -6.78%(-172.60K) | $81.83(+39.52%) | 2026-03-31 | |
| SYRE | SPYRE THERAPEUTICS INC | 3.77% | 3.78M | $190.8M | +23.26%(+714.00K) | $26.04(+232.69%) | 2026-03-31 | |
| NUVL | NUVALENT INC | 3.2% | 1.58M | $161.9M | -5.08%(-84.60K) | $45.99(+169.05%) | 2026-03-31 | |
| EWTX | EDGEWISE THERAPEUTICS INC | 2.76% | 4.42M | $139.4M | -0.76%(-34.00K) | $21.05(+87.95%) | 2026-03-31 | |
| PTGX | PROTAGONIST THERAPEUTICS INC | 2.57% | 1.23M | $129.7M | -8.85%(-119.55K) | $38.41(+242.70%) | 2026-03-31 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative |
|---|---|---|
| Top 20 Holdings Weighted | +26.47% | +102.31% |
| Top 20 Holdings Unweighted | +24.82% | +94.46% |
Sign up free to track Perceptive Advisors LLC, compare funds side by side, and get alerts the moment positions change.